Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone replacement in hypogonadal men after myocardial infarction
NCT02803073Phase 3Withdrawn
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Aug 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone cypionate in Hypogonadism, sponsored by Texas Tech University Health Sciences Center. Planned start Aug 2016; status: withdrawn.
02
Drugs
testosterone cypionate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02803073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02803073.